Response evaluation of SGLT2 inhibitor therapy in patients with type 2 diabetes mellitus using 18F-FDG PET/MRI.

Sazan RasulBarbara Katharina GeistHelmut BrathPascal BaltzerLalith Kumar Shiyam SundarVerena PichlerMarkus MitterhauserAlexandra Kautzky-WillerMarcus Hacker

Published in: BMJ open diabetes research & care (2021)

NCT03557138.

Keyphrases

pet ct
positron emission tomography
pet imaging
computed tomography
magnetic resonance imaging
contrast enhanced
diffusion weighted imaging
stem cells
magnetic resonance
bone marrow
cell therapy